Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Irene Martignago"'
Autor:
Maurizio Severino, Livio Simioni, Patrizia Bonadonna, Renato Cantone, Gabriele Cortellini, Stefano Crescioli, Anna D'Angelo, Luigi La Rosa, Donatella Macchia, Irene Martignago, Alessandro Massolo, Federico Reccardini, Diego Bagnasco, Giovanni Passalacqua
Publikováno v:
World Allergy Organization Journal, Vol 12, Iss 12, Pp - (2019)
Introduction: It is acknowledged that any claim of efficacy of allergen immunotherapy must be done for each specific product, and this remains true also for venom immunotherapy (VIT). Thus, we evaluated the efficacy and safety of a specific tyrosine-
Externí odkaz:
https://doaj.org/article/ec7f5c402ba748cbb1bae558132043fe
Autor:
Erminia Ridolo, Cristoforo Incorvaia, Irene Martignago, Laura Pessina, Fulvio Lauretani, Luciano Loperfido, Gian Galeazzo Riario-Sforza, Annalisa Broglia, Bruna L. Gritti, Lorenzo Panella
Publikováno v:
Clinical and Molecular Allergy, Vol 16, Iss 1, Pp 1-5 (2018)
Abstract Background Based on meta-analyses results, it is currently acknowledged that there is an increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) undergoing inhaled corticosteroids (ICS) treatment. However, t
Externí odkaz:
https://doaj.org/article/45822007e2874952aad9adead881b1b6
Autor:
Maria Teresa Ventura, Elisa Boni, Rosa Cecere, Rosalba Buquicchio, Gian Franco Calogiuri, Irene Martignago, Cristoforo Incorvaia, Erminia Ridolo
Publikováno v:
Clinical and Molecular Allergy, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background The use of drugs in the elderly is very extensive because of the frequent occurrence of chronic diseases. Adverse drug reactions (ADRs) commonly occur in geriatric patients receiving multiple therapeutic regimens. In the literatur
Externí odkaz:
https://doaj.org/article/dea56cf4e8bd47f9aa687c0dc4c20ae1
Publikováno v:
Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-4 (2017)
Abstract The discovery of an exclusive local production of IgE antibodies dates back to the 1970s, but only recently the pathophysiology of such phenomenon was deeply investigated, leading to the concept of local allergic rhinitis (LAR). Currently, L
Externí odkaz:
https://doaj.org/article/218de1d3ded04245b78534534c95a6d9
Autor:
Erminia Ridolo, Anti Rogkakou, Maria Teresa Ventura, Irene Martignago, Cristoforo Incorvaia, Gabriele Di Lorenzo, Giovanni Passalacqua
Publikováno v:
Clinical and Molecular Allergy, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Asthma, allergic rhinitis (AR) and atopic dermatitis are very common in young people, but in the latest decades it was increasingly recognized that also individuals of higher ages, including the population over 65 years, are concerned. Actua
Externí odkaz:
https://doaj.org/article/c1f264396ff84258be75f0d86e01f1af
Publikováno v:
Clinical and Molecular Allergy, Vol 15, Iss 1, Pp 1-5 (2017)
Abstract Allergen immunotherapy (AIT) is the only treatment that works on the causes of allergy. Available AIT nowadays are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) for allergic rhinitis and asthma, while for allergy to H
Externí odkaz:
https://doaj.org/article/b7f8554da5be45958e971d63e553491c
Publikováno v:
Gastroenterology Research and Practice, Vol 2019 (2019)
Background. Up to one-third of the patients suffering from eosinophilic esophagitis (EoE) present a refractory form, as defined by nonresponsiveness in clinical, endoscopic, or histological assessment after first-line therapy. Several studies recentl
Externí odkaz:
https://doaj.org/article/9b3802ec03464c7bb21523b839a1af39
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 8-9 (2017)
Externí odkaz:
https://doaj.org/article/fccf1bf6dad8405b904222beb8b4b9b8
Publikováno v:
Current Treatment Options in Allergy. 5:155-165
Allergen immunotherapy (AIT) is aimed at the etiological treatment of respiratory allergy and Hymenoptera venom allergy, while it is still under investigation for food allergy. The incidence of anaphylactic reactions to AIT is generally low, but may
Publikováno v:
Expert Review of Clinical Immunology. 14:61-68
Atopic dermatitis (AD) is a chronic relapsing skin disease, characterized by flare-up due to the exposure to allergens in patients sensitized to them. Currently, therapy of AD is mainly based on symptomatic treatment and avoidance of irritating/aller